President’s Corner - 

At The Agency, our catch-words for 2012 are “Optimism” and “Opportunity.” What about the Economy? What about the unemployment rate? What about them? The overall unemployment rate is improving (slowly), and the same can be said regarding the Economy. Plus, 2012 is a presidential election year in the US, and the World will be coming together to celebrate human achievement via the Summer Olympics in London. All are ingredients for optimism.

The opportunities lie in the industry’s need to continue to innovate, push boundaries, and replenish pipelines. 2011 saw plenty of mergers, acquisitions and partnerships put together in BioPharma. 2012 will be the year we see these “events” begin to impact both pipelines and opportunities. Stem cell research and biosimilar development will enhance the demand for top scientists and thought leaders throughout industry and create opportunities across the R&D chain. And no matter the economic climate, top talent is always in demand.

The Agency is currently working on exciting leadership roles across the US, Europe and Australia in Clinical Development, Medical Affairs, Regulatory and Quality. We look forward to making your introduction.

Have a successful 2012!

The Agency Worldwide would like to welcome Jason Troshinsky to the company. With
over a decade of success at Fortune 500 companies, Jason brings his expertise
in market outreach and analysis to The Agency’s recruitment & consulting
division. Jason is responsible for tracking trends, competitive intelligence,
and interfacing with Industry and Academic thought leaders. Everyone at The
Agency is extremely excited about Jason joining the team – and know that his
perspective and life experiences will enhance The Agency’s goal of ensuring our
clients’ success.

When Dagmar Moss joined the Agency in 1999, she knew from the start of her tenure that families, co-workers, businesses and research are all affected on deep levels by the recruiting and placement process. But her passion for connecting the dots, working with incredible people on both ends of the spectrum, and weaving the emotional and professional elements together sustains her drive for success on all levels. While she possesses a breadth of skills and experience that make her an ideal recruiter – tri-lingual, European native, voracious consumer of news and trends in the life sciences industry – it is her ability to understand the whole picture and the many variables of the process that makes her a special member of The Agency Worldwide.

/PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced that David M. Kendall, M.D., currently chief scientific and medical officer of the American Diabetes Association, has been named distinguished medical fellow for Lilly. He will transition from his current role in late-July.

In his new role, Kendall will serve as a senior medical advisor for Lilly Diabetes in advocacy and clinical science communities and as a representative to the professional medical community. In addition, he will help provide scientific direction for Lilly in diabetes discovery and clinical development. Other key responsibilities will include the support of Lilly’s medical education efforts and diabetes healthcare evaluation programs.